PL374696A1 - Zastosowanie pochodnych 4-pirydylometylo-ftalazyny do wytwarzania leku do leczenia zespołów mielodysplatycznych - Google Patents
Zastosowanie pochodnych 4-pirydylometylo-ftalazyny do wytwarzania leku do leczenia zespołów mielodysplatycznychInfo
- Publication number
- PL374696A1 PL374696A1 PL03374696A PL37469603A PL374696A1 PL 374696 A1 PL374696 A1 PL 374696A1 PL 03374696 A PL03374696 A PL 03374696A PL 37469603 A PL37469603 A PL 37469603A PL 374696 A1 PL374696 A1 PL 374696A1
- Authority
- PL
- Poland
- Prior art keywords
- pyridylmethyl
- medicament
- manufacture
- myelodysplastic syndromes
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41317602P | 2002-09-24 | 2002-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374696A1 true PL374696A1 (pl) | 2005-10-31 |
Family
ID=32043216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03374696A PL374696A1 (pl) | 2002-09-24 | 2003-09-23 | Zastosowanie pochodnych 4-pirydylometylo-ftalazyny do wytwarzania leku do leczenia zespołów mielodysplatycznych |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20060128716A1 (pl) |
| EP (1) | EP1545534B1 (pl) |
| JP (1) | JP2006502195A (pl) |
| KR (1) | KR20050074450A (pl) |
| CN (1) | CN100372535C (pl) |
| AT (1) | ATE359789T1 (pl) |
| AU (1) | AU2003299065B2 (pl) |
| BR (1) | BR0314647A (pl) |
| CA (1) | CA2499738A1 (pl) |
| CR (1) | CR7754A (pl) |
| DE (1) | DE60313344T2 (pl) |
| EC (1) | ECSP055700A (pl) |
| ES (1) | ES2285251T3 (pl) |
| HR (1) | HRP20050281A2 (pl) |
| MX (1) | MXPA05003161A (pl) |
| NO (1) | NO20051936L (pl) |
| PL (1) | PL374696A1 (pl) |
| PT (1) | PT1545534E (pl) |
| RS (1) | RS20050228A (pl) |
| RU (1) | RU2353364C2 (pl) |
| WO (1) | WO2004028542A1 (pl) |
| ZA (1) | ZA200502212B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001519366A (ja) * | 1997-10-15 | 2001-10-23 | ポーラクス バイオファーマシュティカルズ，インコーポレーテッド | ヒ素化合物を用いた、原発性および転移性の腫瘍性疾患を治療するための組成物および方法 |
| US7915410B2 (en) | 2005-09-09 | 2011-03-29 | Bristol-Myers Squibb Company | Acyclic IKur inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7132458B2 (en) * | 1994-08-10 | 2006-11-07 | Chemaphor Inc. | Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| JP4673977B2 (ja) * | 1999-03-30 | 2011-04-20 | ノバルティス アーゲー | 炎症性疾患治療用フタラジン誘導体 |
| AR025068A1 (es) * | 1999-08-10 | 2002-11-06 | Bayer Corp | Pirazinas sustituidas y piridazinas fusionadas, composicion farmaceutica que las comprenden, uso de dichos compuestos para la manufactura de un medicamentocon actividad inhibidora de angiogenesis |
| ES2438535T3 (es) * | 1999-12-06 | 2014-01-17 | Geistlich Pharma Ag | Taurolidina o taurultamo para uso en el tratamiento de tumores de próstata, de colon, de pulmón y para el tratamiento del glioblastoma multiforme recurrente |
-
2003
- 2003-09-23 RS YUP-2005/0228A patent/RS20050228A/sr unknown
- 2003-09-23 ES ES03798175T patent/ES2285251T3/es not_active Expired - Lifetime
- 2003-09-23 KR KR1020057004971A patent/KR20050074450A/ko not_active Application Discontinuation
- 2003-09-23 US US10/528,914 patent/US20060128716A1/en not_active Abandoned
- 2003-09-23 AT AT03798175T patent/ATE359789T1/de not_active IP Right Cessation
- 2003-09-23 DE DE60313344T patent/DE60313344T2/de not_active Expired - Lifetime
- 2003-09-23 CA CA002499738A patent/CA2499738A1/en not_active Abandoned
- 2003-09-23 PL PL03374696A patent/PL374696A1/pl not_active Application Discontinuation
- 2003-09-23 RU RU2005112711/14A patent/RU2353364C2/ru not_active IP Right Cessation
- 2003-09-23 BR BR0314647-2A patent/BR0314647A/pt not_active IP Right Cessation
- 2003-09-23 WO PCT/EP2003/010578 patent/WO2004028542A1/en active IP Right Grant
- 2003-09-23 MX MXPA05003161A patent/MXPA05003161A/es active IP Right Grant
- 2003-09-23 PT PT03798175T patent/PT1545534E/pt unknown
- 2003-09-23 JP JP2004538994A patent/JP2006502195A/ja active Pending
- 2003-09-23 CN CNB038227118A patent/CN100372535C/zh not_active Expired - Fee Related
- 2003-09-23 EP EP03798175A patent/EP1545534B1/en not_active Expired - Lifetime
- 2003-09-23 AU AU2003299065A patent/AU2003299065B2/en not_active Ceased
-
2005
- 2005-03-16 ZA ZA200502212A patent/ZA200502212B/en unknown
- 2005-03-17 CR CR7754A patent/CR7754A/es not_active Application Discontinuation
- 2005-03-23 EC EC2005005700A patent/ECSP055700A/es unknown
- 2005-03-23 HR HR20050281A patent/HRP20050281A2/xx not_active Application Discontinuation
- 2005-04-20 NO NO20051936A patent/NO20051936L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2353364C2 (ru) | 2009-04-27 |
| NO20051936L (no) | 2005-06-23 |
| RS20050228A (en) | 2007-08-03 |
| EP1545534B1 (en) | 2007-04-18 |
| WO2004028542A1 (en) | 2004-04-08 |
| MXPA05003161A (es) | 2005-09-12 |
| CN1684684A (zh) | 2005-10-19 |
| ATE359789T1 (de) | 2007-05-15 |
| BR0314647A (pt) | 2005-08-02 |
| RU2005112711A (ru) | 2006-02-27 |
| US20060128716A1 (en) | 2006-06-15 |
| KR20050074450A (ko) | 2005-07-18 |
| PT1545534E (pt) | 2007-06-22 |
| DE60313344D1 (de) | 2007-05-31 |
| CA2499738A1 (en) | 2004-04-08 |
| EP1545534A1 (en) | 2005-06-29 |
| ZA200502212B (en) | 2006-02-22 |
| HRP20050281A2 (en) | 2006-07-31 |
| DE60313344T2 (de) | 2008-01-03 |
| CR7754A (es) | 2005-12-02 |
| ES2285251T3 (es) | 2007-11-16 |
| ECSP055700A (es) | 2005-08-11 |
| JP2006502195A (ja) | 2006-01-19 |
| AU2003299065A1 (en) | 2004-04-19 |
| AU2003299065B2 (en) | 2006-10-26 |
| CN100372535C (zh) | 2008-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329001D1 (en) | 8-hydroxychinolinderivate | |
| YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
| NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
| NO20034549L (no) | Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV | |
| WO2004006842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| AU2003278775A8 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
| MY119375A (en) | Treatment of tinnitus using neuroprotective agents | |
| SE0400184D0 (sv) | New therapeutical use | |
| MXPA05000765A (es) | Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos. | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| GB2368525A (en) | Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease | |
| TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
| EP1178796A4 (en) | AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE | |
| EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
| HK1061817A1 (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
| TW200633700A (en) | Methods of using temozolomide formulation intrathecally in the treatment of cancers | |
| PL374696A1 (pl) | Zastosowanie pochodnych 4-pirydylometylo-ftalazyny do wytwarzania leku do leczenia zespołów mielodysplatycznych | |
| SE0004827D0 (sv) | Therapeutic compounds | |
| ZA200209714B (en) | Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV. | |
| HK1080768A1 (en) | Use of epothilone derivatives for the treatment ofhyperparathyroidism | |
| TW200512183A (en) | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia | |
| ATE346080T1 (de) | Steroid-verbindungen mit anti-tumoraler wirkung | |
| MX2007002532A (es) | Metodos para el tratamiento de enfermedades proliferativas de la piel utilizando derivados de carbazol. | |
| TW200500073A (en) | Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |